Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05968768
Title To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Acronym Butterfly
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Anna Raciborska
Indications
Therapies
Age Groups: adult | child
Covered Countries POL


No variant requirements are available.